Tag Archives: SNMMI

February, 2017

June, 2016

  • 13 June

    Blood Test Predicts Success of Neuroendocrine Cancer Therapy

    San Diego, Calif. – Malignant neuroendocrine tumors (NETs) are relatively rare, notoriously difficult to treat, and associated with poor long-term survival. According to research presented at the 2016 Annual Meeting of the Society of Nuclear Medicine and Molecular Imaging (SNMMI), an investigative blood test could predict how patients will respond …